Zepto is accelerating its IPO plans, targeting to file draft papers by March or April, after securing domicile transfer ...

Zepto secures Singapore approval to move to India, prepares for IPO with $350 million funding round and revenue growth.

The National Company Law Tribunal (NCLT) will hear Zepto's reverse merger application on January 17, with the quick commerce ...

The National Company Law Tribunal (NCLT) will hear Zepto's reverse merger application on January 17, with the quick commerce ...

Zepto plans to file for an IPO around March-April 2024 after securing approval to move its holding entity to India from ...

Zepto is preparing to file for an IPO by March-April 2025 and has received approval to move its holding entity from Singapore ...

Rimini Street faces risks from inflation and geopolitical conflicts. Read why RMNI stock's weakened position led to a ...

Biopharmaceutical company Aptorum Group Ltd. (NASDAQ:APM) saw its pre-market stock price on Tuesday jump by nearly 300 ...

That still puts the new proposed company behind Volkswagen, and far behind Toyota. It would have placed them just above ...

We are excited to announce our Q3 FY-2024 results, a testament to ONAR's extraordinary growth and strategic innovation. This ...

The merger is seen as a way to diversify and strengthen NLS’s pipeline, incorporating Kadimastem’s innovative technologies into the portfolio. It also opens the door for Kadimastem to become a ...

Cara Therapeutics, a Stamford-based biopharmaceutical company, said Friday it plans to conduct a 1-for-12 reverse stock split ...